Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 24 results:
Author Title Type [ Year] Filters: Keyword is Sympathetic Nervous System [Clear All Filters]
Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017). Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?.
Curr Vasc Pharmacol. 16(1), 66-69.
(2017). Renal Sympathetic Denervation: Hibernation or Resurrection?.
Cardiology. 135(2), 87-97.
(2016). New developments in the pathogenesis of obesity-induced hypertension..
J Hypertens. 33(8), 1499-508.
(2015). Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?.
Cardiology. 131(3), 186-8.
(2015). Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure..
Curr Vasc Pharmacol. 12(1), 30-7.
(2014). Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?.
Curr Vasc Pharmacol. 12(1), 2-3.
(2014). The pathophysiological basis of renal nerve ablation for the treatment of hypertension..
Curr Vasc Pharmacol. 12(1), 23-9.
(2014). Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation..
Curr Vasc Pharmacol. 12(1), 55-62.
(2014). Renal nerve ablation for hypertensive patients with chronic kidney disease..
Curr Vasc Pharmacol. 12(1), 47-54.
(2014). Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions..
Circulation. 129(13), 1440-51.
(2014). Renal nerve ablation for resistant hypertension: the dust has not yet settled..
J Clin Hypertens (Greenwich). 16(6), 399-400.
(2014). The role of renal nerve ablation for the management of resistant hypertension and other disease conditions: benefits and concerns..
Curr Vasc Pharmacol. 12(1), 38-46.
(2014). Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis..
Amyotroph Lateral Scler Frontotemporal Degener. 14(5-6), 424-33.
(2013). Metabolic effects of renal denervation..
Curr Clin Pharmacol. 8(3), 206-11.
(2013).
(2012).
Evaluation of autonomic imbalance in patients with heart failure: a preliminary study of pupillomotor function..
Cardiol J. 17(1), 65-72.
(2010). Mechanisms of obesity-induced hypertension..
Hypertens Res. 33(5), 386-93.
(2010).
(2010). Myocardial adrenergic denervation in patients with primary (AL) amyloidosis..
Amyloid. 10(2), 117-20.
(2003).
(2003).
(2002).
(2002).
The relationship between the sympathetic nervous system and the renin-angiotensin system in renovascular hypertension..
Acta Cardiol. 49(5), 425-34.
(1994).